Cargando…
Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritis
Glucocorticoids (GCs) are potent anti-inflammatory agents and are broadly used in treating rheumatoid arthritis (RA) patients, albeit with adverse side effects associated with long-term usage. The negative consequences of GC therapy provide an impetus for research into gaining insights into the mole...
Autores principales: | Lupancu, Tanya J., Lee, Kevin M.C., Eivazitork, Mahtab, Hor, Cecil, Fleetwood, Andrew J., Cook, Andrew D., Olshansky, Moshe, Turner, Stephen J., de Steiger, Richard, Lim, Keith, Hamilton, John A., Achuthan, Adrian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583050/ https://www.ncbi.nlm.nih.gov/pubmed/37860753 http://dx.doi.org/10.1016/j.isci.2023.108079 |
Ejemplares similares
-
CCL17 blockade as a therapy for osteoarthritis pain and disease
por: Lee, Ming-Chin, et al.
Publicado: (2018) -
Glucocorticoids promote apoptosis of proinflammatory monocytes by inhibiting ERK activity
por: Achuthan, Adrian, et al.
Publicado: (2018) -
IL-23 in arthritic and inflammatory pain development in mice
por: Lee, Kevin M.-C., et al.
Publicado: (2020) -
Glucocorticoids promote CCL20 expression in keratinocytes
por: Wang, L., et al.
Publicado: (2021) -
Differential Dermal Expression of CCL17 and CCL18 in Tuberculoid and Lepromatous Leprosy
por: Berrington, William R., et al.
Publicado: (2014)